R
Richard J. Koletsky
Researcher at Case Western Reserve University
Publications - 32
Citations - 1305
Richard J. Koletsky is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Insulin resistance & Moxonidine. The author has an hindex of 17, co-authored 32 publications receiving 1286 citations.
Papers
More filters
Journal ArticleDOI
Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor
TL;DR: The results indicate that the short form of the leptin receptor is involved in the transport of leptin across the blood-brain barrier (BBB) in rats.
Journal ArticleDOI
Ventilation and metabolism among rat strains
Kingman P. Strohl,Agnes J. Thomas,Pamela St. Jean,Evelyn H. Schlenker,Richard J. Koletsky,Nicholas J. Schork +5 more
TL;DR: It is concluded that strain of rats, more than their body mass or sex, has major and different influences on metabolism, the pattern and level of ventilation during air breathing, and ventilation during acute exposure to hypercapnia or hypoxia.
Journal ArticleDOI
The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
TL;DR: The I1-imidazoline receptor is a specific high- affinity binding site corresponding to a functional cell-sur-face receptor mediating the antihypertensive actions of moxonidine and other second-generation centrally-acting agents, and may play a role in countering insulin resistance in an animal model of metabolic syndrome X.
Journal ArticleDOI
Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat
Jacob E. Friedman,Tatsuya Ishizuka,Sha Liu,Craig J. Farrell,David Bedol,Richard J. Koletsky,Hue-lee Cheng Kaung,Paul Ernsberger +7 more
TL;DR: Observations suggest that the leptin receptor mutation fak imposed on a hypertensive background results in extreme hyperinsulinemia, glucose intolerance, and decreased expression of postreceptor insulin signaling proteins in skeletal muscle.
Journal ArticleDOI
Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
TL;DR: Central sympatholytic therapy not only counters hypertension but also insulin resistance, glucose tolerance, and hyperlipidemia in the SHROB model of Syndrome X, and studied the chronic effects of sympathetic inhibition with moxonidine on glucose metabolism inSHROB.